Vanda Pharmaceuticals | VNDA - Lngresos Netos





Lngresos Netos Cambio Fecha
Acadia Pharmaceuticals USD 3.64M 269.93M 2026-03
Agios Pharmaceuticals USD -99.11M 8.93M 2026-03
Akebia Therapeutics USD -12.24M 12.78M 2025-12
Alnylam Pharmaceuticals USD 205.99M 19.57M 2026-03
Anika Therapeutics USD 292K 2.62M 2025-12
Arrowhead Research USD -132.73M 163.54M 2026-03
AstraZeneca USD 3.08B 754M 2026-03
Bristol-Myers Squibb USD 2.68B 1.59B 2026-03
Eli Lilly USD 7.4B 760M 2026-03
Enanta Pharmaceuticals USD -22.29M 93.76M 2024-12
Esperion Therapeutics USD 61.83M 93.16M 2025-12
Halozyme Therapeutics USD 150.05M 291.64M 2026-03
Heron Therapeutics USD -2.95M 14.54M 2025-12
Insmed USD -163.56M 164.92M 2026-03
J&J USD 5.24B 119M 2026-03
Lexicon Pharmaceuticals USD -15.53M 2.76M 2025-12
Ligand Pharmaceuticals USD -13.34M 58.13M 2026-03
Merck USD -4.24B 7.2B 2026-03
Minerva Neurosciences USD 1.44M 21.07M 2024-12
Moderna USD -1.34B 517M 2026-03
Novartis USD 2.41B 1.52B 2025-12
Pfizer USD 2.69B 4.34B 2026-03
PTC Therapeutics USD -2.81M 132.16M 2026-03
Puma Biotechnology USD 20.32M 24.85M 2024-09
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Sanofi EUR 1.61B 2.42B 2026-03
Takeda JPY -24.32B 127.96B 2026-03
Teva Pharmaceutical Industries USD 369M 111M 2026-03
Ultragenyx Pharmaceutical USD -185M 56M 2026-03
Vanda Pharmaceuticals USD -18.9M 13.58M 2024-12
Veracyte USD 28.71M 12.44M 2026-03